Registered entities
Keryx Biopharmaceuticals, Inc.
Reg. No. 134087132United States
Innovation
17 patent families (6 granted) — focus: Human necessities; filing pace steady. Cited 962 times.
| Year | Filings |
|---|---|
| 2015 | 4 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 2 |
Investor mix
8 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 63% |
| Private equity | 1 | 13% |
| Angel & family office | 1 | 13% |
| Other / undisclosed | 1 | 13% |